Vanguard Capital Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$166M Buy
3,600,336
+6,414
+0.2% +$309K ﹤0.01% 1223
2026
Q2
$211M Buy
3,593,922
+61,690
+2% +$2.59M ﹤0.01% 1098
2026
Q1
$114M Buy
+3,532,232
New +$131M ﹤0.01% 1400

Other funds holding VCYT

Vanguard Capital Management's VCYT Position: Q3 2026 in Review

Vanguard Capital Management increased its Veracyte (VCYT) stake by 0.18% in Q3 2026, buying an estimated $309K and bringing the position to 3,600,336 shares worth $166M. The position accounts for ﹤0.01% of the portfolio, ranked #1223.

Vanguard Capital Management first reported a position in VCYT in Q1 2026 and has held it in 3 quarters since. The position peaked at $211M in Q2 2026. 383 funds tracked by Wall St. Rank hold VCYT as of Q3 2026.

  • Vanguard Capital Management held 3,600,336 shares of Veracyte worth $166M as of Q3 2026.
  • Vanguard Capital Management bought 6,414 Veracyte shares in Q3 2026, an estimated $309K.
  • Veracyte made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1223 holding.
  • Vanguard Capital Management first reported a position in Veracyte in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Veracyte position peaked at $211M in Q2 2026.
  • 383 funds tracked by Wall St. Rank held Veracyte as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.